Showing 7 results for Schizophrenia
Masoud Nikfarjam,
Volume 13, Issue 5 (2-2011)
Abstract
Background and aim: Schizophrenia is a chronic illness, and one of the major health problems in the world. So the select of different treatment methods that is appropriate for community culture is very important and necessary issue. The purpose of this study was to investigate the effect of religious training (prayer) on quality of life of schizophrenic inpatients. Materials and methods: 62 schizophrenic inpatients were assigned randomly to two groups: experimental and control. Data were collected via Schizophrenia Quality of Life Scale (SQLS). After two months religious training (prayer) for experimental group (three times a week), all of the subjects were assessed again. Findings: The findings showed that, before intervention there was no significant difference between two groups (t=-1/78, p=0/08). After intervention (religious training), there was significant difference in experimental group (t=2/09, p=0/04). Despite the difference in experimental group, there was no significant difference in control group (t= 1/50, p= 0/14). Conclusion: This study showed that, religious and spiritual training can be increase the satisfaction of quality of life schizophrenic patients.
Azam Davoodi, Hamid Taher Neshat Dust, Hasan Pasha Sharifi,
Volume 14, Issue 4 (9-2011)
Abstract
Background: Different studies have proposed the cognitive deficits as one of the main aspects of schizophrenia furthermore, the presence of psychosis in these patients can influence the degree of deficiency in executive functions .The purpose of this study is to compare the executive function in patients with schizophrenia, non-psychotic major depression and normal individuals.
Materials and Methods: In this cross-sectional study, 28 patients with schizophrenia, 28 patients with non-psychotic major depression and 28 normal subjects were selected from hospitals in Tehran through available sampling method which were matched according to age, sex, and level of education. The executive functions of subjects were evaluated using Wisconsin Card Sorting Test, and data were analyzed using one-way ANOVA and Turkey post-hoc test.
Results: Schizophrenic patients had poorer performance in comparison with non-psychotic depressives and normal individuals in all variables of Wisconsin test (P<0.001). Also, depressive patients showed more preservative error than normal subjects (P<0.001), but no significant difference was found between the two groups in the number of categories and specific error variables.
Conclusion: Greater impairment in the executive functions in the Wisconsin card sorting test is mainly associated with psychosis which might be introduced as a special profile of schizophrenia. Noticing the amount of deficiency in executive functions in each group of patients, the positive or negative prognosis can be diagnosed initially.
Hamid Reza Jamilian, Kamran Bagherzadeh, Zeinab Nazeri,
Volume 14, Issue 6 (1-2012)
Abstract
Background: Major depression is one of the most prevalent psychiatric diseases, whereas schizophrenia is one of the worst human diseases. Therefore, finding low-cost treatment methods with few side effects can be of great help to patients. The present study was done to compare the serum levels of vitamin D, parathyroid hormone, calcium, and phosphorous in individuals with major depression and schizophrenics with healthy subjects.
Materials and Methods: In this cross-sectional study, serum levels of vitamin D, parathyroid hormone, calcium, and phosphorous were assessed in 100 major depressive, 100 schizophrenic, and 100 healthy subjects. Subjects with a history of renal failure, hepatic failure, parathyroid disease, and consumption of vitamin D, parathyroid hormone, calcium, and phosphorous supplements were excluded from the study. SPSS software version 15 was used for data analysis.
Results: Depression was accompanied with decreased serum levels of vitamin D and increased serum levels of parathyroid hormone (p>0.001, p=0.01), but there was not a significant difference between depression and healthy subjects in calcium and phosphorous serum levels (p=0.69, p=0.15). Schizophrenia presented a significant correlation with decreased serum levels of vitamin D and phosphorous (p>0.001, p=0.01), but there was not a significant difference between schizophrenic and healthy subjects in calcium and parathyroid hormone serum levels (p=0.47, p=0.67).
Conclusion: Since depression and schizophrenia are accompanied by decreased serum level of vitamin D, consumption of supplementary vitamin D can be helpful in the treatment of these patients.
Vida Sadeghifard, Ahmad Ebrahimi, Mohamamd Reza Aghasadeghi, Seyed Mehdi Sadat,
Volume 17, Issue 2 (5-2014)
Abstract
Background: Schizophrenia is a widespread neurodegenerative disorder, which affects approximately 1% of the world population. It is a multifactorial and a highly heritable disease to which genetic factors contribute up to approximately 80%. Nowadays, multitude of genes have been discovered that relate to this disorder mostly by affecting the performance and levels of neurotransmitters in neural systems. Since PAI-1 is a considerable gene in the performance of neural systems, the present study dealt with the relationship between -675 4G/5G polymorphism in PAI-1 gene and schizophrenia among Iranian patients.
Materials and Methods: This case-control study was carried out on 106 blood samples collected from individuals suffering from schizophrenia and 122 healthy controls. DNA was extracted from the samples and the frequency of the polymorphisms was analyzed using ARMS-PCR method. Finally, the products were detected on 2% agarose gel electrophoresis.
Results: The analysis of the data for -675 4G/5G polymorphism showed that 17.9% of the patients and 1.6% of the controls were mutant homozygous and 65.1% of the patients and 45.9% of controls were heterozygous. Also, 17% of the patients and 52.5% of the controls were normal homozygous.
Conclusion: There was a significant relationship between PAI-1 4G/5G polymorphism and the incidence of schizophrenia. To the best of our knowledge, this is the first study in Iran that assesses the frequency of the polymorphism among Iranian patients. However, further studies with more samples are necessary.
Akbar Hajizadeh Moghaddam, Asghar Kianmehr,
Volume 19, Issue 5 (8-2016)
Abstract
Background: Schizophrenia is a chronic debilitating psychiatric disorder affecting 1% of the population worldwide. As for key role of free radicals in the development of this disease and that Quince leaf is a natural source of antioxidant substances, this study was aimed to evaluate the protective effects of Quince leaf extract on locomotor activity and anxiety-like behaviors by an intraperitoneal injection of ketamine in male mice in a ketamine model of schizophrenia.
Materials and Methods: In the experimental research, male adult mice were divided into six groups including: control, Sham (received water orally and saline intraperitoneally), psychosis group (received 10 mg/kg/day ketamine i.p. for 10 days) and treated psychosis groups (received 50, 100 and 150 mg/kg/day). Treated groups received hydroalcoholic Quince leaf extract orally for 3 weeks before injection of ketamine. Extract gavages continue for 5 days after the last ketamine injection. Locomotor activity and anxiety-like behavioral changes were measured in the open-field test.
Results: The results showed that chronic administration of ketamine increases horizontal locomotor activity and anxiety like behaviors (p≤0.001) and pretreatment of Quince leaf extract effectively decreases horizontal locomotor activity (p<0.001) and increases duration that spends in middle area of Open field (p<0.01) and vertical ocomotor activity(p<0.001).
Conclusion: The results of this research showed that chronic administration of Quince leaf extract improves locomotor disorder and induced anxiety-like behaviors by having antioxidant properties in a ketamine model of schizophrenia.
Shadi Haghighat, Rasoul Zahmatkesh Roodsari, Reza Ranjbar,
Volume 20, Issue 4 (7-2017)
Abstract
Abstract
Background: Schizophrenia is a common mentaly disorder with high heritability and variable phenotype that they are placed in bipolar nervous disease family. Different genes are associated with this disease that among of them, DAOA gene plays a significant role. DAOA gene is located in the long arm of chromosome 13 and produces a protein called D-amino acid oxidase which is N - metyle D– aspartate (NMDA) receptor activator in the brain. The aim of this study was to investigate the association between DAOA gene polymorphisms and the risk of schizophrenia in Iranian population.
Materials and Methods: In this study, 100 patients with schizophrenia and 100 normal people as a control group were investigated. After genomic DNA extraction from blood samples, allele and genotype frequencies in patients and control group were determined by PCR-RFLP method. Data analysis was performed with Med Calc (ver 12) software.
Results: Frequency of GG, GA, AA genotypes in patients group was 18%, 42%, 40% and in normal group was 14%, 45%, and 41%, respectively. Statistical analysis revealed that there is a significant relationship between DAOA gene polymorphism with schizophrenia disease in the people under the age of 40.
Conclusion: According to the results of this study, the DAOA gene has significant association with schizophrenia in the Iranian population.
Malahat Amani, Hossein Alizade, Esmaeil Shiri,
Volume 20, Issue 10 (1-2018)
Abstract
Abstract
Background: The exact diagnosis of schizophrenic disorder from schizoaffective disorder has always been a challenge for therapists due to the comorbidity of many signs and symptoms. The purpose of this study is to investigate the differential diagnosis of schizophrenia disorder from schizoaffective disorder, focusing on the emotional content of their memories.
Materials and Methods: The present study is a causal-comparative study on 23 male and female patients with schizophrenia and schizoaffective disorder (without any comorbid diagnosis). Using a clinical interview, the emotional events and memories of their lives, as well as the amount of affective and emotional words used by these patients in expressing their memories, have been assessed. To determine the differences between the two groups, the data were analyzed by Chi-square test.
Results: Results showed that men with schizophrenia had a significant difference in expressing the amount of emotional events in their lives, as well as in expressing affective and emotional words compared to schizoaffective men. But, this difference was not observed in schizophrenic and schizoaffective women.
Conclusion: The findings of this study suggest that differential diagnosis of schizophrenia and schizoaffective disorder can be made with emphasis on the emotional content of memories, especially in men.
